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Abstract
Purpose Adiponectin is a predominantly adipocyte-derived
hormone which influences insulin sensitivity and energy ho-
meostasis through at least two receptors, AdipoR1 and
AdipoR2. In animal models, adiponectin may regulate ovarian
steroidogenesis, folliculogenesis, and ovulation. The receptors
AdipoR1 and AdipoR2 are present in the human ovary, but
their regulation is unknown. In these studies, we determined the
effects of LH receptor activation on the expression and function
of the two adiponectin receptors in human granulosa cells.
Methods Granulosa cells were obtained at the time of oocyte
retrieval in women undergoing in vitro fertilization (IVF). Cells
were isolated and cultured for 48 h in DMEM/F12 mediumwith
5%FBS and 50 ug/ml gentamicin.Mediumwas changed to low
serum for 12 h and cells were treated with hCG (100 ng/ml),
forskolin (30 μMol/L), or FSH (1 IU/ml) for 24 h for mRNA
experiments. mRNAwas isolated and RT PCR was performed
using Taqman assays and quantification with the delta delta CT
method. For immunocytochemistry, cells were grown on cham-
ber slides and treated with hCG for 1 to 24 h and fixed with
acetone. ICC was performed with polyclonal rabbit primary
antibodies followed by alexa fluor goat anti-rabbit antibody
and imaging with a fluorescence microscope and Zeiss software
analysis. 3β-hydroxysteroid dehydrogenase (3βHSD) enzyme
activity was determined by measuring the progesterone pro-
duced when cells were provided with an excess of 22-
hydroxy-cholesterol as substrate following an incubation with
hCG (1 IU/ml) and/or adiponectin (10 ng/ml). Progesterone
content in the media was determined by ELISA.
Results Messenger RNA for the two Adiponectin receptors is
differentially regulated by activation of LHR with hCG treat-
ment. AdipoR2 was increased nearly 4-fold (p<0.05), whereas
AdipoR1 expression was not changed by hCG treatment.
Treatment with either FSH or forskolin (an activator of
cAMP) had similar effects. Basal AdipoR2 protein was fairly
low in granulosa cells in culture however treatment of cells with
hCG resulted in a discernible increase in immunodetectable
cytoplasmic protein as early as 6 h after treatment and was
maintained for at least 24 h. The number of cells positive for
AdipoR2 at 6 h increased from a basal of 20 % to almost 60 %
(p<0.05). Adiponectin treatment of hCG-primed cells resulted
in increased 3βHSD activity by approximately 60 % over hCG
alone and more than 3-fold over basal levels.
Conclusions AdipoR2 is regulated by the LH receptor func-
tion via a cAMP dependant mechanism. Increased expres-
sion of adipoR2 prior to and following ovulation may con-
tribute to enhanced 3βHSD activity and increased proges-
terone secretion by the corpus luteum of the ovary.
Dysregulation of adiponectin that may occur with PCOS
may impair normal progesterone production.
Capsule Adiponectin type two receptor is rapidly upregulated by LH
receptor activation via a cAMP dependant mechanism.
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Introduction
Adiponectin is a 30 kDA glycoprotein secreted by adipo-
cytes. It is present in measurable levels in the human circu-
lation as multimer complexes and appears to play critical
roles in both glucose homeostasis and lipid metabolism
[8,19]. In fact, adiponectin is recognized as having unique
insulin-sensitizing, anti-inflammatory, and anti- atherogenic
properties [18, 23]. Adiponectin signals by binding one of
two distinct seven—transmembrane domain containing re-
ceptors, known as AdipoR1 and AdipoR2 [29]. Activation
of these cell membrane bound receptors can then activate
the AMP activated protein kinase (AMPK), peroxisome
proliferator activated receptor alpha (PPARα) and mitogen
activated protein kinase (MAPK). The relative activation of
receptors and downstream signaling can vary in different
cell and tissue types. [29].
Interestingly, levels of adiponectin are paradoxically de-
creased with increasing adiposity [21, 28]. Thus, adiponectin
may be an important biologic mediator, linking obesity to
inflammation and insulin resistance in addition to its potential
roles in the pathogenesis of other weight-related comorbidities
such as type 2 diabetesmellitus, and atherosclerosis [9, 11]. Of
special importance to reproduction, adiponectin has been im-
plicated in the pathogenesis of the polycystic ovary syndrome
(PCOS) [12, 27]. Both lean and obese women with PCOS
demonstrate lower circulating levels of adiponectin compared
with BMI-matched normal control women, with levels of
adiponectin correlating inversely with estimates of insulin
resistance [6, 27]. Moreover, single nucleotide polymorphsims
in the adiponectin gene are more prevalent in PCOS women
compared with non-PCOS controls [12].
Studies also suggest a functional role of adiponectin in
reproduction. Adiponectin and its receptors are expressed in
the ovary of various species, including pig, chicken and rat
[2, 3]. Adiponectin is also present in follicular fluid at levels
similar to serum [10, 25]. Adiponectin treatment does not
appear to alter the expression of its own receptors in ovarian
granulosa cells [10]. However, adiponectin treatment of
granulosa cells from pig or rat does influence the expression
of several genes associated with steroidogenesis and
periovulatory events [2, 10]. AdipoR1 and AdipoR2, but
not adiponectin, were expressed in human primary
granulosa cells [4]. In addition, adiponectin does not alter
cell proliferation or basal steroidogenesis but does augment
IGF1 induced effects on human granulosa cells [4].
Although hCG treatment of rats increased the expression
of AdipoR1 in whole ovaries, the expression of AdipoR2
was not changed. The temporal effect of gonadotropins on
adiponectin receptor expression and function in human
granulosa cells is unknown.
The granulosa cells of the dominant and luteinizing
follicles express both the gonadotropin receptors FSHR
and LHR. These two receptors are very similar and
share considerable homology. They are both 7 trans-
membrane serpentine receptors that both activate
cAMP and the protein kinase A signaling pathway via
the stimulatory G protein complex (Gs), though they
may have differing capabilities to activate other signal-
ing cascades. FSH is the ligand for FSHR, but both LH
and hCG can activate the hCG receptor. [15]
In these studies, we determined the role of gonadotropins
on the cellular expression and function of adiponectin recep-
tors in human granulosa cells and explored the functional
interaction of adiponectin and LH in luteal granulosa cells.
Materials and methods
Isolation and culture of granulosa cells
Human granulosa cells were collected from preovulatory folli-
cles during oocyte retrieval for IVF, under an IRB-approved
protocol. Samples were centrifuged (300×g and 600×g, at
room temperature for 5 min each). The cells were then brought
to a 1 ml volume using culture medium (DMEM/F12
supplemented with 5%FBS and 50ug/ml gentamicin). Cells
were further purified by carefully layering the 1 ml cell suspen-
sion on top of 5 mls of 45 % Percoll:DMEM/F12 solution and
then centrifuged at 300×g for 30 min at 25°Cs. The top 1 ml
containing cell layer was carefully removed from the Percoll
and washed 2× with 10 ml culture medium at 600×g 5 min at
room temperature. The pellet was resuspended in fresh medium
(DMEM/F12) and cells were counted in a hemocytometer
using trypan blue dye exclusion for viability testing. The cells
were plated for 48 h in DMEM/F12 supplemented with seleni-
um (25 nmol/L), human transferrin (5 mg/L), 0.1 % low insulin
bovine serum albumin, and 5 % fetal bovine serum. The
medium was then replaced with serum-free medium overnight
prior to treatment with media containing the specific experi-
mental treatments. Following treatment, cells were collected for
RNA isolation or fixed for immunohistochemistry. Human
chorionic gonadotropin (hCG), forskolin, selenium, human
transferrin and 0.1 % low insulin bovine serum albumin were
obtained from Sigma (Sigma-Aldrich Corporation, St Louis,
MO). Adiponectin was obtained from Alexis Biochemicals
(San Diego CA.).
RNA extraction and RT-PCR
Total RNA was isolated from human granulosa cells using
TRIzol reagent (Invitrogen, Grand Island NY) with the
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PurelinkTM RNA Miniprep according to the manufacturer’s
protocol and stored at −80 0C. RNA was quantified by
measuring the absorbance at 260 nm and 280 nm. The RT
cDNA synthesis reactions were performed using oligo (dT)
M-MLV RT (Ambion, Austin TX) under the conditions
described by the manufacturer, and PCR products were
verified by electrophoresis and sequencing.
For real-time PCR, the TaqMan assay system was used
(Applied Biosystems, Foster City CA)with specific probes for
TBP (4333769 T), AdipoR1 (Hs00360422_m1), and
AdipoR2 (Hs00226105_m1). The real-time PCR reaction
was completed on an ABI 7,500 Thermocycler (Applied
Biosystems) with 2 min at 50 °C, 10 min at 95 °C, followed
by 45 cycles with 15 s at 95 °C (melting) and 1 min at
60 °C(annealing/extension). The CT value was determined
for each duplicate reaction using Sequence Detection
Software version 1.7a (Applied Biosystems), and comparative
analysis was completed using the delta- delta CTmethod [14].
TBP is a well- characterized housekeeping gene [7] that is
expressed at low levels, similar in magnitude to anticipated
AdipoR1 and AdipoR2 expression.
Immunohistochemistry
For immunohistochemistry, granulosa cells were plated
and grown in chamber slides (Labtec, Napierville IL).
Cell were treated with hCG for various times as de-
scribed prior to fixation with cold acetone. Fixed cells
were blocked with BSA and 1 % serum, then slides
were incubated with rabbit polyclonal primary anti-
bodies (1:100 dilution; Phoenix Pharmaceuticals Inc,
Burlingame CA) overnight at 4 oC in a humidified
container. Slides were then washed and incubated with
Alexa Fluor goat anti-rabbit antibody (1:1,000 dilution;
Invitrogen) for 1 h at room temperature. Slides were
mounted with Dapi mounting media (Vector Labs, Inc,
Burlingame CA) and imaged, including measuring the
mean intensity of fluorescence per cell, with a ZEISS
Axiovert 40 with X-Cite Series 120 fluorescence.
Progesterone production from exogenous substrate
The enzyme 3β-hydroxysteroid dehydrogenase (3BHSD) me-
tabolizes pregnenolone to progesterone. When provided with
unlimited substrate, the amount of progesterone produced over
time serves as an indicator of 3BHSD enzyme activity. In these
studies, excess 22-hydroxy- cholesterol (Sigma) was used as a
substrate because it readily enters steroidogenic cells and is
rapidly converted to progesterone in the presence of 3βHSD
([5, 16]). However the final reaction in the chain mediated by
CYP11A1 (SCC) is also needed to cleave the bond between
carbons 20 and 22 resulting in pregnenolone.
Fig. 1 AdipoR1 (gray bars) and AdipoR2 (blue bars) mRNA expres-
sion in human granulosa cells cultured for 24 h with or without hCG
(10 IU), Forskolin (10 uM) or FSH (10 IU). Experiment was repeated
at least 7 times with different cell isolations. Bars represent average
with SEM. * represents difference from control (p<0.05)
Fig. 2 Fluorescence (a, c, e)
and phase contrast (b, d, f)
micrographs of human
granulosa cells cultured with
hCG (10 IU) at 0 h (a, b), 6 h (c,
d), and 24 h (e, f). Cells were
incubated with an antibody for
AdipoR2 and imaged as
described in materials and
methods. The positive signal is
seen as red. In Fig. 2g, at least
100 cells from 4 different cell
isolations were imaged and
counted for positive staining for
AdipoR2 with defined
thresholds as described in
materials and methods. Bars
represent averages with SEM. *
represents significantly
different from control (p<0.05)
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Granulosa cells were plated as previously described and
the plating medium was replaced with serum free medium
24 h prior to the enzyme assay. Six hours prior to the
enzyme assay, the cells were changed to serum-free medium
containing 1 IU/ml hCG. Following this incubation, the
cells were rinsed well and the medium was changed to
DMEM/F12 containing 5 mM 22-0H cholesterol as sub-
strate and 10 ng/ml adiponectin in the presence and absence
of hCG (1 IU/ml). After 2 h, the media was removed and
frozen at −80 °C until the progesterone assay was
performed. The cells were collected and assayed for protein
content. Data is presented as progesterone produced in
nanograms per mg of protein per hour.
Progesterone content of the media was measured using an
enzyme-linked immunosorbent assay (ALPCO, Salem NH),
according manufacture instructions. The assays were read on
a plate reader using standard curves that were created using
blankmedium as the diluent. All samples were run in duplicate.
Results
Adiponectin receptor mRNA is differentially regulated
in granulosa cells treated with gonadotropins
The effects of gonadotropins on the expression of mRNA
for AdipoR1 and AdipoR2 were evaluated in cultured
granulosa cells (Fig. 1). Both FSH and hCG (as a surrogate
for LH) treatment increased AdipoR2 mRNA by more than
2-fold. When cells were treated with forskolin, an activator
of adenylate cyclase, an increase in AdipoR2 mRNA of a
similar magnitude was observed, supporting that activation
of the PKA/cAMP pathway is the mechanism action of
gonadotropin regulation of AdipoR2. In contrast, AdipoR1
mRNA was not substantially increased by any of these
treatments.
AdipoR2 intracellular protein is increased by treatment
with hCG in a time dependant manner
Basal expression of AdipoR2 protein was fairly low in
cultured granulosa cells (Fig. 2a). However, treatment with
hCG resulted in a discernible increase in immunodetectable
cytoplasmic protein as early as 6 h after treatment (Fig. 2c),
and was maintained up to 24 h (Fig. 2e). Cells staining
positively for AdipoR2 increased from a basal of 20 % to
almost 60 % following hCG treatment (Fig. 2g).
Adiponectin enhances 3βHSD activity in granulosa cells
treated with hCG
In order to determine if there was a physiological rele-
vance to the regulation of AdipoR2 by gonadotropins,
we determined the effect of treatment with adiponectin
on hCG-stimulated 3βHSD activity as reflected by
timed granulosa cell progesterone production when pre-
cursor substrate was provided in excess (Fig. 3). In
cells that had been pretreated with hCG for 6 h,
adiponectin alone had no effect on 3βHSD activity over
basal conditons. As expected, treatment with hCG in-
creased progesterone production, but the combination of
Fig. 3 3-β-hydroxysteroid dehydrogenase activity of cells incubated
for 2 h with or without hCG (10 IU) and adiponectin (25 ng/ml). a is















Fig. 4 A schematic of the events within the granulosa cell depicting
how the interactions of LHR and adiponectin might occur. LH or hCG
binds and activates the LH receptor which increases cAMP and acti-
vates the PKA pathway of signal transduction. This increases AdipoR2
mRNA expression and also results in the translocation of R2 to the cell
membrane. Adiponectin binding of AdipoR2 activates an as-yet
undetermined signaling pathway and increases the production of
Progesterone from the 22OH-cholesterol substrate
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adiponectin and hCG increased progesterone production
by approximately 60 % over hCG alone and more than
3-fold over basal levels (Fig. 3).
Discussion
In this series of experiments, we have demonstrated that 1)
treatment of luteinized granulosa cells with either hCG or FSH
upregulates AdipoR2 but not AdipoR1 mRNA expression; 2)
hCG treatment of granulosa cells rapidly induces cytoplasmic
expression of the AdipoR2; and 3) that adiponectin is able to
augment the hCG-stimulated activity of the 3βHSD enzyme.
(summarized in Fig. 4). Collectively, these data suggest that
adiponectin, working through the AdipoR2 receptor, plays a
role in the rapid up-regulation of progesterone secretion after
the LH surge. Thus, dysregulation of this system could ad-
versely impact luteal secretion of progesterone.
Although it had been posited that AdipoR1 was the
primary adiponectin receptor regulated by gonadotropin in
granulosa cells [3], in this study we have demonstrated that
the activation of the cAMP pathway by either hCG, FSH or
forskolin upregulate expression of AdipoR2 to a much
greater extent than AdipoR1 in primary human granulosa
cells. This result is in contrast to the response following the
injection of intact rats with hCG and evaluating whole ovary
expression of the receptors [3]. Specifically, under these
circumstances AdipoR1 was greatly upregulated but R2
was not. However, use of whole ovary lysates may have
obscured more subtle changes in the granulosa cells of
periovulatory follicles. A recent study of mouse ovaries
demonstrating that mural and cumulus granulosa cells dif-
ferentially express the receptors for adiponectin confirms
this possibility [22]. It is also possible that there are
species-specific differences in the role of the receptors in
ovarian cell function or that the state of differentiation of the
cultured cells influences adiponectin responses.
In our studies, the basal protein level for AdipoR2 was low
in cultured human primary granulosa cells. This is consistent
with reports of others that R2 expression is low in both
primary cells and the KGN granulosa cell tumor line [3, 20].
However, following treatment with hCG, AdipoR2 expression
was increased relatively quickly and remained stably
expressed.We are unaware of other reports of the acute effects
of hCG stimulation on AdipoR2 expression in human
granulosa cells. These acute effects are particularly relevant
in a process that is as time dependant as ovulation. The
increased availability of LH to dominant follicle granulosa
cells in the hours prior to ovulation could stimulate an increase
in cytoplasmic AdipoR2 in the periovulatory follicle.
Adiponectin is present in follicle fluid, may be produced by
oocytes and theca ([1, 3, 13, 24]), and is readily available to
dominant follicle mural and cumulus granulosa cells.
We also found that adiponectin treatment of granulosa
cells resulted in an acute increase in hCG-stimulated pro-
duction of progesterone from exogenous substrate, strongly
suggesting an effect on the activity of 3BHSD. Interestingly,
adiponectin did not have a significant effect on enzyme
activity under basal conditions. These findings demonstrate
the potential physiologic significance of gonadotropin-
stimulated expression of AdipoR2 on the acute effects of
adiponectin on 3βHSD activity in granulosa cells and the
corpus luteum and suggest that adiponectin may play a role
in the rise in progesterone production leading up to and
following ovulation.
Taking all of our data together, we propose the fol-
lowing paradigm. The increasing availability of LH to
granulosa cells of the dominant follicle during the LH
surge results in the rapid upregulation of the expression
of functional AdipoR2 receptors. These receptors would
then be able to respond to the adiponectin in the follic-
ular fluid and augment the LH stimulated 3βHSD activ-
ity, thus increasing early progesterone production by the
dominant follicle. Though many factors are known to
play roles in augmenting progesterone production by the
luteal cells, the association of the adiponectin pathway
with progesterone secretion is intriguing because of the
known association of obesity and PCOS (states charac-
terized by decreased levels of adiponectin) with ovulatory
and luteal dysfunction [17].
Furthermore it has been shown that adiponectin levels
can increase in women with PCOS and obesity when they
lose weight [26]. Thus, increases in adiponectin levels may
contribute to the improved reproductive function observed
in women who are successful at weight loss. Although this
paradigm likely over simplifies the complex ovarian physi-
ology, our data does encourage further studies of the specific
roles of adiponectin signaling in human reproductive phys-
iology including the transition of cells from follicular
granulosa cells into corpus luteal cells.
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